“is Fast-Acting for GLP-1 Induced Heartburn”
Evidence →We found no study of this product measuring the stated outcome over the stated timeframe.
Exact product checked · GTIN 00307663074226TUMS · checked Aug 9, 2026 · on sale since Nov 3, 2023🇺🇸 USPTO wordmark owner · GlaxoSmithKline Consumer Healthcare (US) IP LLC · DELAWARE, USA
Quick read · TUMS
TUMS Gummy Bites Antacid Tablets
Checked against public sources on August 9, 2026 · LookCloser does not sell or recommend supplements.
108gummies
Does the marketing hold up?
🇺🇸 Brand owner: GlaxoSmithKline Consumer Healthcare (US) IP LLC · limited liability company, DELAWARE, USA. This tells you who is behind the brand and where the trademark record points. It does not by itself identify the manufacturer.
Is the dose real?Can’t check — no panel filed
What a serving costsNo price found for this exact barcode
Is it tested?No testing claim made
Who’s behind it?🇺🇸GlaxoSmithKline Consumer Healthcare (US) IP LLClimited liability company · DELAWARE, USA
Is it the real thing?✓Barcode matches outside records
Trouble on record?✓No recalls found
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
1△ support not foundno contradictions · no recalls
Marketing claims, checked
The checks, one by one
1 promise needs a closer look.
△Claimed without support found1
Quick read · 1 useful finding
What is worth knowing.
Headlines first. Open evidence only when you want the source trail.
CheckedCan you trust the review pattern?
We can see 12 of this product’s 307 reviews — the count rose between April 25 and July 28, 2026. That is too small a slice to say anything about the wider pattern.
A count that moves steadily is ordinary. A sudden burst is what deserves a closer look.
Evidence and sources
Written reviews rose from 295 to 307 between April 25 and July 28, 2026. The largest rise inside any single 30-day window was about 4, so the count moved in steps rather than in one burst.
Locked evidence record →Open the full source-linked findingWhat remains open 3
- No FDA recall matched this brand in the current search.
- We have not found a public label filing for this exact product.
- Barcode checksum is valid; no independent product record was found.
These are evidence gaps, not strikes against the product.
Who owns the brand wordmark?
🇺🇸
GlaxoSmithKline Consumer Healthcare (US) IP LLCLimited Liability Company · exact supplement-class mark for TUMS +
Filed address
251 Little Falls Drive, Wilmington, DELAWARE 19808, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
Where it sells
Price check for this exact product
Amazon
Exact UPC/GTIN match$20.50
matching UPC/GTIN · checked Aug 9, 2026
View on Amazon ↗iHerb
Not confirmedNo exact listing saved
We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search iHerb ↗Target
Not confirmedNo exact listing saved
We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Target ↗Walmart
Not confirmedNo exact listing saved
We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Walmart ↗Only one exact price was available at build time; prices change by date, seller, and promotion.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
Want to inspect the evidence?
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built August 09, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.